You're reading the free version. Trader adds the live tape and alerts.
Start tracking
UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Sep 21, 2026
Sale
Calculated transaction value
$1.09M
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Sep 18, 2026
Public filing date
Sep 21, 2026
Filing lag
Filed 3 days later
UTHR daily price context
Close on/before transaction
$494.63
Sep 18, 2026
First close after public filing
$497.59
Sep 22, 2026
30-day return after filing
+13.24%
Through Oct 21, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,216 shares @ $493.78
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000145
Filing cohort
Transactions in this filing
Showing 8 of 8
Trades
8
Issuers
1
Estimated value
$5.82M
Buys / sales
0 / 6
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Sep 18, 2026 | $1.12M |
| United Therapeutics Corp UTHR | Sale | Sep 18, 2026 | $122.24K |
| United Therapeutics Corp UTHR Current | Sale | Sep 18, 2026 | $1.09M |
| United Therapeutics Corp UTHR | Sale | Sep 18, 2026 | $2.11M |
| United Therapeutics Corp UTHR | Sale | Sep 18, 2026 | $1.15M |
| United Therapeutics Corp UTHR | Sale | Sep 18, 2026 | $79.72K |
| United Therapeutics Corp UTHR | Exercise | Sep 18, 2026 | $0 |
| United Therapeutics Corp UTHR | Sale | Sep 18, 2026 | $137.57K |